Uso de antihipertensivos como factor protector para fractura no traumática de cadera

Nuñez  Marinovich-Milenka

doi:10.37711/rpcs.2023.5.3.423

Authors

Nuñez Marinovich-Milenka Universidad Privada Antenor Orrego, La Libertad-Trujillo, Perú https://orcid.org/0009-0004-7654-2014

DOI:

https://doi.org/10.37711/rpcs.2023.5.3.423

Keywords:

antihypertensives, risk reduction, nontraumatic, fracture

Abstract

Objective. To determine whether the use of antihypertensives is associated with reduced risk of nontraumatic hip fracture in patients at Hospital Belén de Trujillo, 2017-2022. Methods. A retrospective, analytical, cross-sectional study was conducted. According to the selection criteria, 160 adult patients were included and divided into 2 groups: with or without nontraumatic hip fracture; then, the prevalence ratio and the chi-square statistical test were applied. Results. Mean age and frequency of osteoporosis were significantly higher in the group of patients with hip fracture (p < 0.05). The consumption of thiazide antihypertensives was a protective factor for non-traumatic hip fracture, with a prevalence ratio of 0.29, which was significant (p < 0.05). The use of beta-blockers was a protective factor for non-traumatic hip fracture, with a prevalence ratio of 0.30, which was significant (p < 0.05). The use of ARBs was a protective factor for non-traumatic hip fracture, with a prevalence ratio of 0.26, which was significant (p < 0.05). The consumption of ACEI was not a protective factor for non-traumatic hip fracture, with a prevalence ratio of 1.11, which was not significant (p > 0.05). Conclusions. The use of antihypertensives is associated with decreased risk of nontraumatic hip fracture in patients at Hospital Belén de Trujillo, 2017-2022 (level of evidence III-B)

Downloads

Download data is not yet available.

References

Downey C, Kelly M, Quinlan J. Changing trends in the mortality rate at 1year post hip fracture - a systematic review. World J Orthop [Internet]. 2019 [Consultado 2023 Nov 8]; 10: 166-75. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428998/

Kanis J, Odén A, McCloskey E. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis international [Internet]. 2012 [Consultado 2023 Nov 8]; 23:2239–56. Disponible en: https://pub-med.ncbi.nlm.nih.gov/22419370/

European guidance for the diagnosis and management of osteoporosis in postmenopausal women [Internet] [Consultado 2023 Nov 8]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026233/

Desai R, Mahesri M, Abdia Y. Association of osteoporosis medication use after hip fracture with prevention of subsequent Nonvertebral fractures: an instrumental variable analysis. JAMA Netw Open [Internet].2018 [Consultado 2023 Nov 8]; 2(4): 222-34. Disponible en: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2688348

Thuy L, Achat H, Loh S. Validity of routinely collected data in identifying hip fractures at a major tertiary hos-pital in Australia. Health Inf Manag[Internet]. 2018 [Consultado 2023 Nov 8]; 47:38–45. https://pubmed.ncbi.nlm.nih.gov/28745563/

Pimentel A. Fractures in patients with CKD—diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney International [Internet]. 2018 [Consultado 2023 Nov 8]; 92: 1343–55. Disponible en:

https://www.kidney-international.org/article/S0085-2538(17)30567-7/fulltext

Toni R. Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up Osteoporosis International. [Internet]. 2020 [Consultado 2023 Nov 8]; 32(3). Disponible en : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026440/

Teng Y, Teng Z, Xu S, Zhang X, Liu J, Yue Q, et al. The Analysis for Anemia Increasing Fracture Risk. Med Sci Monit. [Internet]. 2020 [Consultado 2023 Nov 8]; 2(4): 25-26. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32583812/

Wu Z, Zhao P, Liu B, Yuan Z. Effect of Cigarette Smoking on Risk of Hip Fracture in Men: A Meta-Analysis of 14 Prospective Cohort Studies. PLoS One [Internet]. 2016 [Consultado 2023 Nov 8]; 3(1): 11-12. Disponible en:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201259/

Kunutsor S, Blom A, Whitehouse M, Kehoe P, Laukkanen J. Reninangiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies. Eur J Epidemiol [Internet]. 2017 [Consultado 2023 Nov 8]; 32: 947–59. https://pubmed.ncbi.nlm.nih.gov/28752198/

Barzilay J, Davis B, Pressel S, Ghosh A, Puttnam R, Margolis K, Whelton P. The impact of antihypertensive medications on bone mineral density and fracture risk. Curr Cardiol Rep [Internet]. 2017 [Consultado 2023 Nov 8]; 19:76. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28752275/

Kwok T, Leung J, Barrett-Connor E. Osteoporotic Fractu-res in Men Research G. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Age Ageing [Internet]. 2018 [Consultado 2023 Nov 8]; 46:57–64. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968636/

Xiao Y. Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies Osteoporos Int [Internet]. 2018 [Consultado 2023 Nov 8]; 29(7): 1515-24. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29574519/

Kunutsor S. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies Eur J Epidemiol [Internet]. 2017 [Consultado 2023 Nov 8]; 32(11): 947-59. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28752198/

Canoy D. Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions Osteoporosis International [Internet]. 2020 [Consultado 2023 Nov 8]; 5(8): 14-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34642814/

Holloway K. Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers. Calcif Tissue Int [Internet]. 2022 [Consultado 2023 Nov 8]; 111: 396-408. Disponible en: https://pub-med.ncbi.nlm.nih.gov/35833952/

Canoy D, Copland E, Nazarzadeh M. Efect of antihypertensive drug treatment on long-term blood pressure re-duction: an individual patient-level data meta-analysis of 352,744 participants from 51 large-scale randomised clinical trials. medRxiv. [Internet]. 2021 [Consultado 2023 Nov 8]; 5(2): 13-8. Disponible en:

https://www.medrxiv.org/content/10.1101/2021.02.19.21252066v1

Park J, Yoon Y, Kim K, Hwang I, Lee W, Cho G. Prognostic value of lower bone mineral density in predicting adver-se cardiovascular disease in Asianwomen. Heart. [Internet]. 2021 [Consultado 2023 Nov 8]; 107: 1040–6. Dispo-nible en: https://pubmed.ncbi.nlm.nih.gov/33963047/

Jose M. Uso de antihipertensivos como factor asociado a fractura de cadera en el Hospital Nacional Dos de Mayo enero 2017 – diciembre 2019 [Internet] Lima: Universidad Ricardo Palma; 2020 [Consultado 2023 Nov 7]. Disponible en:

https://hdl.handle.net/20.500.14138/3003

Machin D. Sample size tables and statistical precision. En: Wiley J, editor. Sample size tables for clinical studies. 2nd. Edition. Reino Unido: 2009. Editorial Blackwell Science; p.123-133.

Focchesatto A, Rockett F. Risk and protective factor for the development of chronic diseases in a rural elderly population in Rio Grande do Sul. Rev Bras geriatr y Gerontol. [Internet]. 2015 [Consultado 2023 Nov 8]; 18(4): 779-95.Disponible en: https://doi.org/10.1590/1809-9823.2015.14150

Hedge G, Thaker S, Botchu R, Fawcett R, Gupta H. Atraumatic fractures of the femur. Br J Radiol. [Internet]. 2021 [Consultado 2023 Nov8]; 94: 1402-457. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506166/

Revista Española de Cardiología. Guía ESC/ESH sobre el diagnóstico y tratamiento de la hipertensión arterial. [Internet][Consultado 2023 Nov 8]. Disponible en: https://www.revespcardiol.org/es-guia-esc-esh-2018-so-bre-el-articuloS0300893218306791

Kaufer M. La obesidad: aspectos fisiopatológicos y clínicos. Inter disciplina [Internet]. 2022 [Consultado 2023 Nov 8]; 10(26): 147-75. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S244857052022000100147

Ministerio de Salud. Guía de práctica clínica para el diagnóstico y tratamiento de osteoporosis [Internet] [Consultado 2023 Nov 8]. Disponible en: http://www.es-salud.gob.pe/transparencia/pdf/informacion/guia_osteoporosis 2011.pdf

Sociedad Española de Investigación Ósea y del Metabolismo Mineral [Internet] [Consultado 2023 Nov 8]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0014256522000121